Neurobiological Technologies, Inc.
NTII · OTC
6/30/2010 | 6/30/2009 | 6/30/2008 | 6/30/2007 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $3 | -$16 | -$14 |
| Dep. & Amort. | – | $0 | $0 | $0 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $1 | $1 | $0 |
| Change in WC | – | -$22 | -$6 | $1 |
| Other Non-Cash | – | $1 | $1 | -$0 |
| Operating Cash Flow | – | -$16 | -$21 | -$13 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$0 | -$0 | -$0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | -$42 | -$23 | -$52 |
| Inv. Sales/Matur. | – | $39 | $11 | $54 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$3 | -$12 | $2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | -$6 | $0 |
| Stock Issued | – | $0 | $61 | $7 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | $0 | $0 |
| Financing Cash Flow | – | $0 | $55 | $7 |
| Forex Effect | – | $0 | $0 | $0 |
| Net Chg. in Cash | – | -$20 | $22 | -$4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $28 | $6 | $10 |
| End Cash | – | $8 | $28 | $6 |
| Free Cash Flow | – | -$16 | -$21 | -$13 |